IBRX
IMMUNITYBIO (IBRX)
NASDAQ
$7.94+$0.03 (+0.39%)
Price as of Sep 11, 2026 7:54 PM EDT
  • $8.4B
    Market Cap
  • 204.23%
    1-Year Change
  • Biotechnology
    Industry

Earnings Score

Score: 39
Valuation
IBRX
vs History
vs S&P 500
Profitability
-0
Growth
-0
Low Earnings Volatility
0

Momentum Score

Score: 46
Valuation
IBRX
vs History
vs S&P 500
3-Month Momentum
6.76%
12-Month Momentum
198.84%
3-Month Risk Adjusted Momentum
24.30%
12-Month Risk Adjusted Momentum
192.23%

True Yield

N/A
Valuation
IBRX
vs History
vs S&P 500
Dividend Yield
N/A
Net Buyback Yield
0.54%
Net Debt Paydown Yield
-2.24%

Financial Health Score

Score: 50
Valuation
IBRX
vs History
vs S&P 500
Ohlson's O-Score
-1